Adaptations of REMOTE-CR for Breast Cancer

Following consultation with consumer representatives and the advisory committee, the following changes were made to the base platform for the REMOTE-COR-B trial: (1) expansion of the symptom reporting list to include common breast cancer treatment-related side effects and symptoms (Figure 1); (2) prompts for participants to report their symptoms at the start of each exercise session; (3) ability to report Rating of Perceived Exertion (RPE) both during and after exercise to enhance tailoring of prescription and coaching; (4) expansion of the heart rate data display to include beats per minute (BPM; the raw measurement unit) in addition to heart rate reserve, to allow use when a lack of maximal exercise testing precludes calculation of heart rate reserve; (5) revisions to the behavior change education to provide additional positive reinforcement, breast cancer–specific content, and messages focused on planning, habit formation, and autonomous motivation; and (6) alternative options for wearing the heart rate monitor if chest irritation or pain is an issue (ie, delay enrollment post treatment, use an adhesive to place the sensor on an unaffected area or at a different location that yields sufficient signal quality, or monitor intensity exclusively through RPE).

Expanded symptom reporting list in REMOTE-COR-B: a single-arm feasibility trial for patients with breast cancer.